HOME >> BIOLOGY >> NEWS
The German-Japanese Consortium deciphers human chromosome 21 - A basis for comprehensive understanding of trisomy 21 (Down syndrome)

Chromosome 21 is one of the smallest among the 23 different human chromosomes. It is associated with Trisomy 21, one of the most common genetic diseases (also known as Down syndrome). An extra copy of chromosome 21 results in severely aberrant physical and mental development in children, leading to mental retardation. The disease affects up to 1 in 700 live births. An international collaborative group led by German and Japanese scientists will publish the sequence of chromosome 21 in the journal Nature (18th May 2,000). This work will be freely available on the Nature website from the 8th May. With these findings, the scientists deliver the key for a deeper understanding of the molecular mechanisms of trisomy 21 and other diseases involving chromosome 21, as well as for the design of novel diagnostic tools.

After the successful sequencing of chromosome 22 in December 1999 by a group of international scientists, chromosome 21 is now the second human chromosome which has been deciphered completely. Virtually all genes encoded by chromosome 21 have now been identified by computer-based analysis of the genomic sequence. This tremendous scientific effort was achieved by an international cooperation of scientists from 5 institutions: RIKEN genomic science center, Sagamihara (Japan), the Department of Molecular Biology of Keio University, Tokyo (Japan), the GBF-Gesellschaft fuer Biotechnologishe Forschung, Braunschweig (Germany), the Institut fuer Molekulare Biotechnologie (IMB), Jena (Germany), and the Max Planck Institute for Molecular Genetics, Berlin (Germany).

Historically, sequencing of chromosome 21 started in the early 90's. By 1995, the German-Japanese consortium was formed, with the aim of accomplishing the task of systematic sequencing of all of the 33.546.361 base pairs of chromosome 21. Altogether, a total of 170 people have worked on this international project. The German Ministry of Education and Science (BMBF) has financed the German groups
'"/>

Contact: Dr. Jrg Wadzack
wadzack@dhgp.de
49-303-263-9171
Max-Planck-Gesellschaft
7-May-2000


Page: 1 2 3

Related biology news :

1. ORNL earns four Federal Laboratory Consortium awards
2. Academy Harbor Consortium releases letter on mercury to President Bush
3. International HapMap Consortium publishes scientific strategy
4. Consortium for Archaeal Genomics and Proteomics established at Penn State
5. Penn State to lead Atlantic Slope Consortium with a $6 million grant from U.S. EPA
6. Consortium focuses on new mouse models of human cancers
7. NIAMS funds the North American Spondylitis Consortium
8. New Consortium Of Nutrition And Medical Experts Takes On The Lack Of Nutrition Education In Medical Training
9. Climate change plus human pressure caused large mammal extinctions in late Pleistocene
10. Lycopene slows human prostate tumour growth in mice and combined with vitamin E is even better
11. Most recent common ancestor of all living humans surprisingly recent

Post Your Comments:
(Date:5/23/2013)... the new mechanism by which estrogen suppresses lipid synthesis ... potential new approach toward treating certain liver diseases. ... believe they are changing long-held views in the field. ... the journal Science Signaling . , "The dogma ... been that only receptors located in the nucleus respond ...
(Date:5/23/2013)... WASHINGTON Given the implications for the overall ... should play a primary role in ensuring that ... least 60 minutes per day of vigorous or ... the Institute of Medicine. Recent estimates suggest ... this evidence-based guideline for promoting better health and ...
(Date:5/23/2013)... A new report from the Institute of Medicine says ... at least 60 minutes of vigorous or moderate intensity ... half of American youth meet current evidence-based guidelines of ... physical activity daily, according to the report, which was ... for nearly half of their waking hours, the committee ...
Breaking Biology News(10 mins):UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 3Schools should provide students with daily physical activity, IOM recommends 2
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 The ... encourage all types of inventions. They focus on learning ... noticing this community gravitate toward bringing their ideas to ... DIY Biology Movement, works on making projects using biology. ... DNA of plants to make them glow with bioluminescence ...
(Date:5/23/2013)... 2013 Virobay, Inc. today announced that their ... an important milestone, as Virobay has now initiated a ... cathepsin S inhibitor.   The first Phase ... study designed to evaluate the safety, tolerability, pharmacokinetics and ... "The initiation of this Phase 1 trial ...
(Date:5/23/2013)... , May 23, 2013 Northwest Biotherapeutics (NASDAQ: ... developing DCVax ® personalized immune therapies for solid ... exhibit at this year,s American Society Of Clinical Oncology ... highlight its leadership role in immune therapy.  ... annual meeting is the pre-eminent conference focused on clinical ...
(Date:5/23/2013)... During the conduct of research involving ... principles of good clinical practice (GCP) and human ... Lim, Fellow, Clinical Development at Novartis Pharmaceuticals, will ... the International Conference on Harmonization (ICH) Guideline for ... the conduction of clinical trials ,     Apply ...
Breaking Biology Technology:Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2
Cached News: